Pregled bibliografske jedinice broj: 1200512
Embryonic Stem Cell Patents and Personalized Medicine in the European Union
Embryonic Stem Cell Patents and Personalized Medicine in the European Union // Personalized Medicine: A New Medical and Social Challenge / Bodiroga-Vukobrat, Nada ; Rukavina, Daniel ; Pavelić, Krešimir ; Sander, Gerald G. (ur.).
Cham: Springer, 2016. str. 53-79 doi:10.1007/978-3-319-39349-0_4
CROSBI ID: 1200512 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Embryonic Stem Cell Patents and Personalized Medicine in the European Union
Autori
Mutabžija, Jasmina
Vrsta, podvrsta i kategorija rada
Poglavlja u knjigama, znanstveni
Knjiga
Personalized Medicine: A New Medical and Social Challenge
Urednik/ci
Bodiroga-Vukobrat, Nada ; Rukavina, Daniel ; Pavelić, Krešimir ; Sander, Gerald G.
Izdavač
Springer
Grad
Cham
Godina
2016
Raspon stranica
53-79
ISBN
978-3-319-39347-6
Ključne riječi
Human Embroynic Stem Cell, Somatic Cell Nuclear Transfer, Patents, Inventions
Sažetak
This chapter scrutinizes the legal framework for research and patenting of inventions involving human embryonic stem cells in the European Union. Particular attention is given to the analysis of the relevant provisions of the Directive on Patents in Biotechnology and the two cases in which questions were referred to the CJEU, concerning provisions of the Directive that affect the patentability of human embryonic stem cell inventions. The close examination of Article 6 paragraph 2 items (a) and (c) reveals that the biggest problems in the uniform application of the provisions contained therein are caused by the lack of definitions of some very important terms and concepts, such as “human embryo” and “uses of human embryos.” It is suggested that it is not legally correct to define embryos as to include organisms created by somatic cell nuclear transfer and parthenogenesis for the purposes of the Directive because these organisms cannot complete the development of a human being, and the embryo is protected by the Directive primarily as an entity that has the capability to complete this process. Furthermore, it is put forward that the concept “uses of human embryo” should not encompass uses of human embryos in the stage of research, but it should prevent patentability only if human embryos are used when working the invention. Any wider interpretation would be in conflict with the wording of the general ordre public and morality clause from Article 6 paragraph 1 of the Directive.
Izvorni jezik
Engleski
Znanstvena područja
Pravo
